Alvotech (ALVO) Profit After Tax (2021 - 2026)
Alvotech (ALVO) posted Profit After Tax of $79000.0 for Q1 2026, down 99.96% on a QoQ basis from $192.8 million in Q4 2025, and up 100.04% year-over-year from $39492.9 in Q1 2025.
Alvotech (ALVO) Profit After Tax (2021 - 2026) Analysis & Trends
Alvotech's Profit After Tax history runs 6 years deep, the most recent figure standing at $79000.0 for Q1 2026.
- Quarterly Profit After Tax rose 100.04% year-over-year to $79000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $246.7 million (up 140.1% YoY) and the FY2025 annual result came in at $27.9 million, up 112.04% from the prior year.
- Profit After Tax was $79000.0 for Q1 2026 at Alvotech, down from $192.8 million in the prior quarter.
- Across five years, Profit After Tax topped out at $218.7 million in Q2 2025 and bottomed at -$551.7 million in Q4 2023.
- A 5-year average of -$116.3 million and a median of -$86.9 million in 2023 frame the typical range for Profit After Tax.
- Peak annual rise in Profit After Tax reached 99899.72% in 2025, while the deepest fall reached 99900.0% in 2025.
- Alvotech's Profit After Tax stood at -$513.6 million in 2022, then slipped by 7.43% to -$551.7 million in 2023, then soared by 57.98% to -$231.9 million in 2024, then soared by 183.16% to $192.8 million in 2025, then tumbled by 99.96% to $79000.0 in 2026.
- Business Quant data shows ALVO's Profit After Tax at $79000.0 in Q1 2026, $192.8 million in Q4 2025, and -$164.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.84 Bn | 32.10 Bn | 1.97 Bn | 369.00 Mn |
| 3 | Zoetis | 32.67 Bn | 30.73 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 27.69 Bn | 23.63 Bn | 4.39 Bn | -2.35 Bn |
| 5 | United Therapeutics | 23.12 Bn | 20.97 Bn | 648.10 Mn | 274.90 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.24 Bn | 18.44 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.83 Bn | 16.51 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.22 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Alvotech | 924.10 Mn | 924.10 Mn | 5.09 Mn | 79,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79,000.00 |
| Dec 31, 2025 | 192.82 Mn |
| Sep 30, 2025 | -164.90 Mn |
| Jun 30, 2025 | 218.73 Mn |
| Mar 31, 2025 | -218.73 Mn |
| Dec 31, 2024 | -231.86 Mn |
| Sep 30, 2024 | -164.90 Mn |
| Jun 30, 2024 | 218,729.61 |
| Mar 31, 2024 | -218,729.00 |
| Dec 31, 2023 | -551.73 Mn |
| Aug 31, 2023 | -86.85 Mn |
| Jun 30, 2023 | -86.58 Mn |
| Mar 31, 2023 | -276,180.00 |
| Dec 31, 2022 | -513.58 Mn |
| Aug 31, 2022 | -184.47 Mn |
| Jun 30, 2022 | -107.49 Mn |
| Mar 31, 2022 | -76.98 Mn |
| Dec 31, 2021 | 253.76 Mn |
| Sep 30, 2021 | -81.32 Mn |